Our Company
Innovating Health, Enhancing Lives…
At A Glance
Founded in 2010 and headquartered in London, McDonia Pharmaceuticals is dedicated to improving global health through innovative, safe, and affordable medicines. We launched our first line of generic medicines in 2012, and by 2015, we expanded our R&D facilities to focus on cutting-edge biopharmaceuticals.
In 2018, we achieved regulatory approval for our first biologic therapy, addressing critical unmet medical needs. By 2020, we had partnered with global health organizations to enhance access to essential medicines. Recognized as one of the fastest-growing pharmaceutical companies by 2023, our core values—Innovation, Quality, Integrity, Patient-Centricity, Collaboration, and Sustainability—guide our mission. With a diverse product portfolio that includes generics, biologics, and biosimilars, we serve patients and healthcare providers in over 50 countries. McDonia Pharmaceuticals remains committed to leading pharmaceutical innovation and improving lives worldwide.
Our Company
Fast Growing Pharma Company
McDonia Pharmaceuticals is a fast-growing company dedicated to improving global health through innovative and affordable medicines. Our commitment to quality and safety drives our rapid expansion as we develop and distribute a wide range of pharmaceuticals. Leveraging cutting-edge research, our expert team addresses diverse healthcare needs, enhancing patient well-being and advancing medical science.
“Our rapid growth is fueled by our unwavering commitment to innovation, quality, and patient well-being. We strive to make a meaningful impact on global health every day.”
Dr Collin Clark
Founder, CEO of McDonia Pharmaceuticals
Therapeutic Areas of Focus
Neurology and Oncology
We are dedicated to advancing healthcare through our focus on neurology and oncology. In neurology, we develop innovative treatments for disorders such as Alzheimer’s, Parkinson’s, epilepsy, and multiple sclerosis, aiming to improve patients’ quality of life through cutting-edge science and collaborations with leading experts.
In oncology, our mission is to transform cancer care by developing advanced treatments, including targeted therapies and immunotherapies. We partner with top oncologists and research centers to deliver effective and accessible cancer treatments, providing new hope for patients and their families.
Awards & Recognition
2023
2023
2023
2023
2022
2022
2022
